Unlock your academic potential and expand your network by joining us!

Chunbin Zou

Dr. Chunbin Zou

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicin...

Share Link

Share

Information

Chunbin Zou is an associate professor in the Acute Lung Injury Center of Excellence at the University of Pittsburgh School of Medicine. He completed his MD training at the University of South China and his PhD degree at Juntendo University in Japan. He conducted his postdoctoral training at the University of California at San Francisco and the University of Pittsburgh. His lab has been supported by the NIH and the American Heart Association. His lab at the University of Pittsburgh focuses on the protein stability of chromatin modulators in acute lung injury and acute infection. Microbial pathogens may alter the molecular behavior of critical chromatin modulators and protein degradation enzymes to augment- the pathogenesis of acute lung injury. Understanding the underlying molecular mechanisms may help to develop novel pharmaceutical strategies against acute lung injury.

Research Keywords & Expertise

Epigenetics
Infection
Inflammation
Signal Transduction
acute lung injury

Fingerprints

38%
Infection
23%
Epigenetics
19%
acute lung injury
15%
Inflammation
8%
protein stability

Short Biography

Chunbin Zou is an associate professor in the Acute Lung Injury Center of Excellence at the University of Pittsburgh School of Medicine. He completed his MD training at the University of South China and his PhD degree at Juntendo University in Japan. He conducted his postdoctoral training at the University of California at San Francisco and the University of Pittsburgh. His lab has been supported by the NIH and the American Heart Association. His lab at the University of Pittsburgh focuses on the protein stability of chromatin modulators in acute lung injury and acute infection. Microbial pathogens may alter the molecular behavior of critical chromatin modulators and protein degradation enzymes to augment- the pathogenesis of acute lung injury. Understanding the underlying molecular mechanisms may help to develop novel pharmaceutical strategies against acute lung injury.